Showing results (2751-2760 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|April 1, 2026
Gastric and Rectal Administration of Encorafenib with Targeted Chemotherapy against BRAF V600E-Mutant Rectal Cancer with Bowel ObstructionMaximilian Alexander Funk, Volker Heinemann, Veit Bücklein, et al.
The Oncologist|May 4, 2026
Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castrate-resistant prostate cancer: a pooled analysisAbhiraj Saxena, Marc Yorker, Nicholas A Zorko, et al.
The Oncologist|May 1, 2026
Female sex is associated with worse survival in laryngeal head and neck squamous cell carcinomaAlexandria G Yao, Amber Arif, Chloe A Paolucci, et al.
The Oncologist|May 1, 2026
Acupressure for anxiety: A pilot study of a nurse-led acupressure intervention for patients receiving chemotherapyLaura Rhee, Susanne Cutshall, Abbey Metzger, et al.
The Oncologist|May 7, 2026
Prolonged response to Pembrolizumab in BRAFV600E microsatellite stable metastatic colorectal cancer following an increase in tumour mutational burdenYu-Hsuen Yang, Naureen Starling, Elizabeth Cartwright
The Oncologist|May 7, 2026
The Association Between Financial Toxicity and Mortality in Hematologic Malignancies: A Systematic Review and Meta-AnalysisFang Liao, Qiu-Xia Xu, Ping Lin, et al.
The Oncologist|April 30, 2026
Proactive Identification of Candidates for Newly-Approved Targeted Therapies Using a Clinical Decision Support ProgramRebecca Feldman, Farah Abdulla, Andrew Hinton, et al.
The Oncologist|April 29, 2026
Exploring Biologically-Based Complementary and Alternative Medicine Use Among Irish Cancer Survivors: Findings from a National SurveyClodagh Scannell, Erin Stella Sullivan, Karen Matvienko-Sikar, et al.
The Oncologist|April 12, 2026
Phase 2 Study of Cabozantinib (XL184) with Nivolumab and Ipilimumab for the Treatment of Poorly Differentiated Neuroendocrine Carcinomas (ETCTN10315)Adel Mandl, Ruizhe Chen, Satya Das, et al.
The Oncologist|March 30, 2026
Association Between Pathologic Chemotherapy Response Score and Pattern of Recurrence in Advanced High-Grade Serous Ovarian CancerFrancesco Mezzapesa, Antonio De Leo, Camelia Alexandra Coada, et al.
Pageof 571